The regulatory effects of PTPN6 on inflammatory process: Reports from mice to men
- 17 March 2022
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 721, 109189
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- A clinical perspective of IL‐1β as the gatekeeper of inflammationEuropean Journal of Immunology, 2011
- Spontaneous Insertion of a B2 Element in the Ptpn6 Gene Drives a Systemic Autoinflammatory Disease in Mice Resembling Neutrophilic Dermatosis in HumansThe American Journal of Pathology, 2011
- Alteration in the Gene Encoding Protein Tyrosine Phosphatase Nonreceptor Type 6 (PTPN6/SHP1) May Contribute to Neutrophilic DermatosesThe American Journal of Pathology, 2011
- Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseasesClinical and Experimental Immunology, 2010
- The Inflammasomes: Guardians of the BodyAnnual Review of Immunology, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial triggerProceedings of the National Academy of Sciences, 2008
- PTPN22: Its role in SLE and autoimmunityAutoimmunity, 2007
- Regulation of SHP-1 Tyrosine Phosphatase in Human Platelets by Serine Phosphorylation at Its C TerminusJournal of Biological Chemistry, 2004